Back
82· Surging
Health & Science1d 19h ago
The FDA has granted landmark approval for 'Casgevy,' the world's first medicine to utilize CRISPR/Cas9 gene-editing technology for the treatment of sickle cell disease.
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA)
What
The FDA has granted landmark approval for 'Casgevy,' the world's first medicine to utilize CRISPR/Cas9 gene-editing technology for the treatment of sickle cell disease.
When
Sun, 07 Jun 2026 14:40:06 GMT · 1d 19h ago
Where
Silver Spring, Maryland, USA · 39.0331°N, 77.0319°W
Why
The decision follows clinical trials demonstrating that the therapy can effectively eliminate painful crises in patients by modifying their own blood stem cells.
The Frontline Impact
How this affects you
This marks a historic milestone in genetic medicine, offering a potential one-time cure for a debilitating blood disorder while paving the way for future gene-editing treatments.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.